These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 28616428)
21. Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension. Barnett AH; Patel S; Harper R; Toorawa R; Thiemann S; von Eynatten M; Woerle HJ Diabetes Obes Metab; 2012 Dec; 14(12):1145-54. PubMed ID: 22974280 [TBL] [Abstract][Full Text] [Related]
22. A comparison of the gastrointestinal side effects of two forms of erythromycin. Anastasio GD; Robinson MD; Little JM; Leitch BB; Pettice YL; Norton HJ J Fam Pract; 1992 Nov; 35(5):517-23. PubMed ID: 1431767 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trial. Cai XL; Chen YL; Zhao JJ; Shan ZY; Qiu MC; Li CJ; Gu W; Tian HM; Yang HZ; Xue YM; Yang JK; Hong TP; Ji LN Chin Med J (Engl); 2015 May; 128(10):1279-87. PubMed ID: 25963345 [TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori infection decreases metformin tolerance in patients with type 2 diabetes mellitus. Huang Y; Sun J; Wang X; Tao X; Wang H; Tan W Diabetes Technol Ther; 2015 Feb; 17(2):128-33. PubMed ID: 25391019 [TBL] [Abstract][Full Text] [Related]
25. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults. Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901 [TBL] [Abstract][Full Text] [Related]
26. What is the phenotype of patients with gastrointestinal intolerance to metformin? Hermans MP; Ahn SA; Rousseau MF Diabetes Metab; 2013 Sep; 39(4):322-9. PubMed ID: 23786968 [TBL] [Abstract][Full Text] [Related]
27. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770 [TBL] [Abstract][Full Text] [Related]
28. Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review. Mohamed S Medicine (Baltimore); 2024 Oct; 103(43):e40221. PubMed ID: 39470509 [TBL] [Abstract][Full Text] [Related]
29. Metformin-Induced Chronic Diarrhea Misdiagnosed as Irritable Bowel Syndrome for Years. Chaudhary M; Midha NK; Sukhadiya P; Kumar D; Garg MK Cureus; 2024 Mar; 16(3):e56828. PubMed ID: 38654785 [TBL] [Abstract][Full Text] [Related]
32. Metallothionein-Kidney Bean Polyphenol Complexes Showed Antidiabetic Activity in Type 2 Diabetic Rats by Improving Insulin Resistance and Regulating Gut Microbiota. Zuo Z; Pang W; Sun W; Lu B; Zou L; Zhang D; Wang Y Foods; 2023 Aug; 12(16):. PubMed ID: 37628138 [TBL] [Abstract][Full Text] [Related]
33. A comparison of the effects of cinnamon, ginger, and metformin consumption on metabolic health, anthropometric indices, and sexual hormone levels in women with poly cystic ovary syndrome: A randomized double-blinded placebo-controlled clinical trial. Dastgheib M; Barati-Boldaji R; Bahrampour N; Taheri R; Borghei M; Amooee S; Mohammadi-Sartang M; Wong A; Babajafari S; Mazloomi SM Front Nutr; 2022; 9():1071515. PubMed ID: 36523331 [TBL] [Abstract][Full Text] [Related]
34. Huangshan Maofeng Green Tea Extracts Prevent Obesity-Associated Metabolic Disorders by Maintaining Homeostasis of Gut Microbiota and Hepatic Lipid Classes in Leptin Receptor Knockout Rats. Wu G; Gu W; Cheng H; Guo H; Li D; Xie Z Foods; 2022 Sep; 11(19):. PubMed ID: 36230016 [TBL] [Abstract][Full Text] [Related]
35. Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro. Guo T; Sun X; Yang J; Yang L; Li M; Wang Y; Jiao H; Li G BMC Microbiol; 2022 Sep; 22(1):215. PubMed ID: 36089583 [TBL] [Abstract][Full Text] [Related]
36. From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease. Poznyak AV; Litvinova L; Poggio P; Moschetta D; Sukhorukov VN; Orekhov AN Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077136 [TBL] [Abstract][Full Text] [Related]
37. Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management. Nurcahyanti ADR; Cokro F; Wulanjati MP; Mahmoud MF; Wink M; Sobeh M Front Nutr; 2022; 9():891339. PubMed ID: 35757255 [TBL] [Abstract][Full Text] [Related]
38. Ghatti gum-base graft copolymer: a plausible platform for pH-controlled delivery of antidiabetic drugs. Bhosale RR; Osmani RAM; Abu Lila AS; Khafagy ES; Arab HH; Gowda DV; Rahamathulla M; Hani U; Adnan M; Gangadharappa HV RSC Adv; 2021 Apr; 11(24):14871-14882. PubMed ID: 35423983 [TBL] [Abstract][Full Text] [Related]
39. A Qualitative Exploration of Self-Management Behaviors and Influencing Factors in Patients With Type 2 Diabetes. Peng X; Guo X; Li H; Wang D; Liu C; Du Y Front Endocrinol (Lausanne); 2022; 13():771293. PubMed ID: 35250851 [TBL] [Abstract][Full Text] [Related]
40. Metformin as a Potential Adjuvant Antimicrobial Agent Against Multidrug Resistant Bacteria. Masadeh MM; Alzoubi KH; Masadeh MM; Aburashed ZO Clin Pharmacol; 2021; 13():83-90. PubMed ID: 34007223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]